Specifically, we confirmed that the profiles corresponded to expected pleural mesothelioma-specific alterations, including changes in the BAP1 and MTAP/CDKN2A gene regions (Additional File 5). This evidence concerns the gene CDKN2A and pleural mesothelioma.